Crossref
Are Chinese Oncology Trials Generalizable to Non-Chinese Patients? A Call for Systematic Evidence
Clinical Oncology Letters · 2026 · 6 · e2026008
DOI: 10.4322/col.2026.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oncology Letters, 2026. Verfasst von Auro del Giglio und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Giglio, A. D., & Cubero, D. (2026). Are Chinese Oncology Trials Generalizable to Non-Chinese Patients? A Call for Systematic Evidence. Clinical Oncology Letters, 6, e2026008. https://doi.org/10.4322/col.2026.008
Vancouver
Giglio AD, Cubero D. Are Chinese Oncology Trials Generalizable to Non-Chinese Patients? A Call for Systematic Evidence. Clinical Oncology Letters. 2026;6:e2026008. doi:10.4322/col.2026.008
BibTeX
@article{Giglio2026,
author = {Giglio, Auro del and Cubero, Daniel},
title = {Are Chinese Oncology Trials Generalizable to Non-Chinese Patients? A Call for Systematic Evidence},
journal = {Clinical Oncology Letters},
year = {2026},
volume = {6},
pages = {e2026008},
doi = {10.4322/col.2026.008}
}
EUVIMED